Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
148.43
-0.12 (-0.08%)
At close: Feb 11, 2026, 4:00 PM EST
147.17
-1.26 (-0.85%)
After-hours: Feb 11, 2026, 7:44 PM EST
Insmed Stock Forecast
Stock Price Forecast
The 22 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $192.27, which forecasts a 29.54% increase in the stock price over the next year. The lowest target is $115 and the highest is $256.
Price Target: $192.27 (+29.54%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 10 | 10 | 10 | 12 | 12 |
| Buy | 8 | 7 | 7 | 9 | 10 | 10 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 19 | 21 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $157 → $162 | Hold | Maintains | $157 → $162 | +9.14% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $231 | Buy | Initiates | $231 | +55.63% | Jan 28, 2026 |
| Roth Capital | Roth Capital | Strong Buy Initiates $212 | Strong Buy | Initiates | $212 | +42.83% | Jan 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $197 → $200 | Buy | Maintains | $197 → $200 | +34.74% | Jan 21, 2026 |
| UBS | UBS | Strong Buy Maintains $223 → $215 | Strong Buy | Maintains | $223 → $215 | +44.85% | Jan 6, 2026 |
Financial Forecast
Revenue This Year
572.99M
from 363.71M
Increased by 57.54%
Revenue Next Year
1.38B
from 572.99M
Increased by 141.54%
EPS This Year
-6.11
from -5.57
EPS Next Year
-3.06
from -6.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 637.1M | 1.8B | ||||
| Avg | 573.0M | 1.4B | ||||
| Low | 440.0M | 882.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 75.2% | 217.8% | ||||
| Avg | 57.5% | 141.5% | ||||
| Low | 21.0% | 53.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.44 | -1.02 | ||||
| Avg | -6.11 | -3.06 | ||||
| Low | -6.78 | -4.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.